Skip to content

Preoperative Bath in Patients Submitted to Hip Arthroplasty

Preoperative Bath in Patients Submitted to Hip Arthroplasty: Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03001102
Enrollment
162
Registered
2016-12-22
Start date
2015-08-31
Completion date
2018-03-31
Last updated
2019-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound Infection

Keywords

Preoperative Care, Baths, Chlorhexidine, Soaps, Povidone-Iodine, Arthroplasty, Replacement, Hip, Surgical Wound Infection

Brief summary

Clinical trial for prevention, randomized, controlled, blinded, parallel, with three arms which purpose is verify the effects of nursing intervention preoperative bathing with 4% chlorhexidine gluconate, 10% Povidone iodine (PVPI) and soap without antiseptic, for the prevention of surgical site infection (SSI) in patients undergoing hip arthroplasty.

Detailed description

Despite the recommendation in several guidelines of preoperative bathing with 4% chlorhexidine gluconate as a measure for the prevention of SSI, there is no evidence in the literature that support this practice. The objective of this study is to evaluate the effect of nursing intervention: preoperative bath using 4% chlorhexidine gluconate solutions, 10% povidone iodine degermante or soap without antiseptic for the prevention of SSI in patients undergoing elective hip arthroplasty surgery. The specific objectives are to compare the incidence of SSI in the three interventions, to assess the most effective intervention for the prevention of surgical infection and to estimate the frequency of allergic reactions caused by the use of the solutions. Two intervention groups (4% Chlorhexidine gluconate and PVPI10%) and a control group (without antiseptic soap) composed of 52 patients undergoing hip arthroplasty in each group will be randomized to perform the baths in the period from may 2015 to june 2017. Before the intervention, nasal swabs will be collected of patients to investigate colonization by Staphylococcus aureus. The expected result is lower ISC rate with the proposed measures.

Interventions

Cationic biguanide - antimicrobial action rubbing in the skin.

DEVICE10% PVPI degermante

Polymer soluble in water of iodine with polyvinylpyrrolidone (PVP) - antimicrobial action rubbing in the skin.

DEVICESoap without antiseptic

Liquid soap with glycerin, neutral pH. Skin cleansing

Sponsors

Fundação de Amparo à Pesquisa do estado de Minas Gerais
CollaboratorOTHER
Federal University of Minas Gerais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Be 18 or older; * Elective procedure of total hip arthroplasty * No report of infectious focus at the surgical site * Know to respond to the clinical signs of a surgical infection or having a person responsible with this ability * Do not be a nasal carrier of Staphylococcus aureus before surgery * Have access to fixed or mobile phone

Exclusion criteria

* Patient treating surgical site infection * Emergency hip prosthesis surgery or orthopedic trauma * Nasal carriers of Staphylococcus aureus before surgery * Previous history of allergic reactions to the products used in the bat

Design outcomes

Primary

MeasureTime frameDescription
Infection of Surgical Site (SSI)During the first 90 days after surgeryThe infections that develop after the surgical procedure

Secondary

MeasureTime frameDescription
Allergic reactionsIn the first hours after procedureAdverse reaction to a given product

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026